APA (7th ed.) Citation

CS, S., P, A., T, L., C, L., RC, D., X, L., . . . D, L. (2020). Pharmacokinetics of polatuzumab vedotin in combination with R/G-CHP in patients with B-cell non-Hodgkin lymphoma. Cancer chemotherapy and pharmacology, 85(5), 831. https://doi.org/10.1007/s00280-020-04054-8

Chicago Style (17th ed.) Citation

CS, Shemesh, et al. "Pharmacokinetics of Polatuzumab Vedotin in Combination with R/G-CHP in Patients with B-cell Non-Hodgkin Lymphoma." Cancer Chemotherapy and Pharmacology 85, no. 5 (2020): 831. https://doi.org/10.1007/s00280-020-04054-8.

MLA (9th ed.) Citation

CS, Shemesh, et al. "Pharmacokinetics of Polatuzumab Vedotin in Combination with R/G-CHP in Patients with B-cell Non-Hodgkin Lymphoma." Cancer Chemotherapy and Pharmacology, vol. 85, no. 5, 2020, p. 831, https://doi.org/10.1007/s00280-020-04054-8.